Anterior Segment Complications Following Intravitreal Injection
Klinische Monatsblätter für Augenheilkunde · 01.08.2024 · 241 (08) · 917-922
DOI: 10.1055/a-2349-2224 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.08.2024. Verfasst von Lars H B Mackenbrock und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital Heidelberg, Germany. Hauptthemen laut MEDLINE: Intravitreal Injections, Anterior Eye Segment, Hyphema, Cataract. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Intravitreal injections (IVI s) have gained increased popularity in the past decades and are used to treat a multitude of ailments. In 2010, the total number of IVI s surpassed the number of cataract surgeries performed, making it the most common procedure in ophthalmology. As the number of injections increases, so does the number of injected-related complications. While complications in the posterior segment, such as retinal detachment or endophthalmitis, are detrimental to visual function and have therefore been well documented, IVI s can also lead to complications in the anterior segment. These include hyphema, inflammation of the sterile anterior segment (incidence rate of 0.05 to 1.1% depending on the drug), implant migration with corneal decompensation (incidence rate of 0.43%), iatrogenic lens damage (incidence rate of 0.07%), accelerated cataract formation (up to 50% for steroids and 10.9% for anti-VEGF), and an increased complication rate during subsequent cataract surgery (up to 4% per IVI). Most of these complications occur immediately and have a good prognosis if treated correctly. However, the increased risk of complications during subsequent surgery demonstrates that IVI s can also have long-term complications, a topic that needs to be explored further in future research projects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital Heidelberg, Germany.
ORCID-Profile: Lars H B Mackenbrock, Gerd U Auffarth, Tadas Naujokaitis, Lucy J Kessler, Ramin Khoramnia
Zitieren
APA
Mackenbrock, L. H. B., Auffarth, G. U., Albrecht, M., Naujokaitis, T., Kessler, L. J., Mayer, C. S., & Khoramnia, R. (2024). Anterior Segment Complications Following Intravitreal Injection. Klinische Monatsblätter für Augenheilkunde, 241(08), 917-922. https://doi.org/10.1055/a-2349-2224
Vancouver
Mackenbrock LHB, Auffarth GU, Albrecht M, Naujokaitis T, Kessler LJ, Mayer CS, et al. Anterior Segment Complications Following Intravitreal Injection. Klinische Monatsblätter für Augenheilkunde. 2024;241(08):917-922. doi:10.1055/a-2349-2224
BibTeX
@article{Mackenbrock2024,
author = {Mackenbrock, Lars H B and Auffarth, Gerd U and Albrecht, Michael and Naujokaitis, Tadas and Kessler, Lucy J and Mayer, Christian S and Khoramnia, Ramin},
title = {Anterior Segment Complications Following Intravitreal Injection},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2024},
volume = {241},
number = {08},
pages = {917--922},
doi = {10.1055/a-2349-2224}
}
EUVIMED